Everlab, a preventive healthcare startup that performs full-body MRI scans to screen for potential problems in asymptomatic patients, is ready for international expansion after closing off one of Australia’s largest seed rounds for 2025.
The Melbourne-based start-up has secured $15 million in seed funding in a round led by Left Lane Capital, a New York and London-based venture capital and growth equity firm. The funds will fuel Everlab’s international expansion efforts into Europe, the United States and across the Asia-Pacific in 2026, and grow its clinic network and develop the platform.